|
1
|
He X, Sun Y, Lei N, Fan X, Zhang C, Wang
Y, Zheng K, Zhang D and Pan W: MicroRNA-351 promotes
schistosomiasis-induced Liver fibrosis by targeting the vitamin D
receptor. Proc Natl Acad Sci USA. 115:180–185. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao Q, Zhu X, Zhai X, Ji L, Cheng F, Zhu
Y, Yu P and Zhou Y: Leptin suppresses microRNA-122 promoter
activity by phosphorylation of foxO1 in hepatic stellate cell
contributing to leptin promotion of mouse liver fibrosis. Toxicol
Appl Pharmacol. 339:143–150. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chandel R, Saxena R, Das A and Kaur J:
Association of rno-miR-183-96-182 cluster with diethyinitrosamine
induced liver fibrosis in Wistar rats. J Cell Biochem.
119:4072–4084. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Afonso MB, Rodrigues PM, Simão AL, Gaspar
MM, Carvalho T, Borralho P, Bañales JM, Castro RE and Rodrigues
CMP: miRNA-21 ablation protects against liver injury and
necroptosis in cholestasis. Cell Death Differ. 25:857–872. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen Y, Ou Y, Dong J, Yang G, Zeng Z, Liu
Y, Liu B, Li W, He X and Lan T: Osteopontin promotes collagen I
synthesis in hepatic stellate cells by miRNA-129-5p inhibition. Exp
Cell Res. 362:343–348. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wan Y, McDaniel K, Wu N, Ramos-Lorenzo S,
Glaser T, Venter J, Francis H, Kennedy L, Sato K, Zhou T, et al:
Regulation of cellular senescence by miR-34a in alcoholic liver
injury. Am J Pathol. 187:2788–2798. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brea R, Motiño O, Francés D, García-Monzón
C, Vargas J, Fernández-Velasco M, Boscá L, Casado M, Martín-Sanz P
and Agra N: PGE2 induces apoptosis of hepatic stellate cells and
attenuates liver fibrosis in mice by downregulating miR-23a-5p and
miR-28a-5p. Biochim Biophys Acta Mol Basis Dis. 1864:325–337. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cai Y, Huang G, Ma L, Dong L, Chen S, Shen
X and Zhang S, Xue R, Sun D and Zhang S: Smurf2, an E3 ubiquitin
ligase, interacts with PDE4B and attenuates liver fibrosis through
miR-132 mediated CTGF inhibition. Biochim Biophys Acta Mol Cell
Res. 1865:297–308. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Caviglia JM, Yan J, Jang MK, Gwak GY, Affo
S, Yu L, Olinga P, Friedman RA, Chen X and Schwabe RF: MicroRNA-21
and Dicer are dispensable for hepatic stellate cell activation and
the development of liver fibrosis. Hepatology. 67:2414–2429. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y, Yang S, Peng Y and Yang Z: The
regulatory role of IL-6R in hepatitis B-associated fibrosis and
cirrhosis. Braz J Med Biol Res. 50:e62462017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang N, Wu Y, Cao W, Liang Y, Gao Y, Hu L,
Yang Q, Zhou Y, Tang F and Xiao J: Lentivirus-mediated
over-expression of let-7b microRNA suppresses Liver fibrosis in the
mouse infected with Schistosoma japonicum. Exp Parasitol.
182:45–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen W, Zhao W, Yang A, Xu A, Wang H, Cong
M, Liu T, Wang P and You H: Integrated analysis of microRNA and
gene expression profiles reveals a functional regulatory module
associated with liver fibrosis. Gene. 636:87–95. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma X, Luo Q, Zhu H, Liu X, Dong Z, Zhang
K, Zou Y, Wu J, Ge J and Sun A: Aldehyde dehydrogenase 2 activation
ameliorates CCl4-induced chronic liver fibrosis in mice by
up-regulating Nrf2/HO-1 antioxidant pathway. J Cell Mol Med.
22:3965–3978. 2018. View Article : Google Scholar
|
|
14
|
Wang XC, Gusdon AM, Liu H and Qu S:
Effects of glucagon-like peptide-1 receptor agonists on
non-alcoholic fatty liver disease and inflammation. World J
Gastroenterol. 20:14821–14830. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Patel V, Joharapurkar A, Kshirsagar S,
Sutariya B, Patel M, Patel H, Pandey D, Patel D, Ranvir R, Kadam S,
et al: Coagonist of GLP-1 and glucagon receptor ameliorates
development of non-alcoholic fatty liver disease. Cardiovasc
Hematol Agents Med Chem. 16:35–43. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ye Y, Li Z, Feng Q, Chen Z, Wu Z, Wang J,
Ye X, Zhang D, Liu L, Gao W, et al: Downregulation of microRNA-145
may contribute to liver fibrosis in biliary atresia by targeting
ADD3. PLoS One. 12:e01808962017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng GX, Li J, Yang Z, Zhang SQ, Liu YX,
Zhang WY, Ye LH and Zhang XD: Hepatitis B virus X protein promotes
the development of liver fibrosis and hepatoma through
downregulation of miR-30e targeting P4HA2 mRNA. Oncogene.
36:6895–6905. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tao R, Fan XX, Yu HJ, Ai G, Zhang HY, Kong
HY, Song QQ, Huang Y, Huang JQ and Ning Q: MicroRNA-29b-3p prevents
Schistosoma japonicum-induced liver fibrosis by targeting COL1A1
and COL3A1. J Cell Biochem. 119:3199–3209. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen J, Yu Y, Li S, Liu Y, Zhou S, Cao S,
Yin J and Li G: MicroRNA-30a ameliorates Liver fibrosis by
inhibiting Beclin1-mediated autophagy. J Cell Mol Med.
21:3679–3692. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun J, Zhang H, Li L, Yu L and Fu L:
MicroRNA-9 limits Liver fibrosis by suppressing the activation and
proliferation of hepatic stellate cells by directly targeting
MRP1/ABCC1. Oncol Rep. 37:1698–1706. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schueller F, Roy S, Loosen SH, Alder J,
Koppe C, Schneider AT, Wandrer F, Bantel H, Vucur M, Mi QS, et al:
miR-223 represents a biomarker in acute and chronic liver injury.
Clin Sci (Lond). 131:1971–1987. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Demerdash HM, Hussien HM, Hassouna E and
Arida EA: Detection of microRNA in hepatic cirrhosis and
hepatocellular carcinoma in hepatitis C genotype-4 in Egyptian
patients. BioMed Res Int. 2017:18060692017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fittipaldi S, Vasuri F, Bonora S,
Degiovanni A, Santandrea G, Cucchetti A, Gramantieri L, Bolondi L
and D'Errico A: miRNA signature of hepatocellular carcinoma
vascularization: How the controls can influence the signature. Dig
Dis Sci. 62:2397–2407. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu N, Meng F, Zhou T, Han Y, Kennedy L,
Venter J, Francis H, DeMorrow S, Onori P, Invernizzi P, et al:
Prolonged darkness reduces liver fibrosis in a mouse model of
primary sclerosing cholangitis by miR-200b down-regulation. FASEB
J. 31:4305–4324. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sene LB, Rizzi VHG, Gontijo JAR and Boer
PA: Gestational low-protein intake enhances whole-kidney miR-192
and miR-200 family expression and epithelial-to-mesenchymal
transition in rat adult male offspring. J Exp Biol. 221:2212018.
View Article : Google Scholar
|
|
26
|
Wu Y, Liu Y, Pan Y, Lu C, Xu H, Wang X,
Liu T, Feng K and Tang Y: MicroRNA-135a inhibits cardiac fibrosis
induced by isoproterenol via TRPM7 channel. Biomed Pharmacother.
104:252–260. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Glasgow AMA, De Santi C and Greene CM:
Non-coding RNA in cystic fibrosis. Biochem Soc Trans. 46:619–630.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miao C, Xiong Y, Zhang G and Chang J:
MicroRNAs in idiopathic pulmonary fibrosis, new research progress
and their pathophysiological implication. Exp Lung Res. 44:178–190.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lai CY, Lin CY, Hsu CC, Yeh KY and Her GM:
Liver-directed microRNA-7a depletion induces nonalcoholic fatty
liver disease by stabilizing YY1-mediated lipogenic pathways in
zebrafish. Biochim Biophys Acta Mol Cell Biol Lipids. 1863:844–856.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Watany MM, Hagag RY and Okda HI:
Circulating miR-21, miR-210 and miR-146a as potential biomarkers to
differentiate acute tubular necrosis from hepatorenal syndrome in
patients with liver cirrhosis: A pilot study. Clin Chem Lab Med.
56:739–747. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shi SQ, Ke JJ, Xu QS, Wu WQ and Wan YY:
Integrated network analysis to identify the key genes,
transcription factors, and microRNAs involved in hepatocellular
carcinoma. Neoplasma. 65:66–74. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schueller F, Roy S, Vucur M, Trautwein C,
Luedde T and Roderburg C: The role of miRNAs in the pathophysiology
of liver diseases and toxicity. Int J Mol Sci. 19:192018.
View Article : Google Scholar
|
|
34
|
Lin YC, Wang FS, Yang YL, Chuang YT and
Huang YH: MicroRNA-29a mitigation of toll-like receptor 2 and 4
signaling and alleviation of obstructive jaundice-induced fibrosis
in mice. Biochem Biophys Res Commun. 496:880–886. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Austermann C, Schierwagen R, Mohr R,
Anadol E, Klein S, Pohlmann A, Jansen C, Strassburg CP,
Schwarze-Zander C, Boesecke C, et al: microRNA-200a: A
stage-dependent biomarker and predictor of steatosis and liver cell
injury in human immunodeficiency virus patients. Hepatol Commun.
1:36–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhu W, Wang Y, Zhang D, Yu X and Leng X:
MiR-7-5p functions as a tumor suppressor by targeting SOX18 in
pancreatic ductal adenocarcinoma. Biochem Biophys Res Commun.
497:963–970. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng J, Wang W, Yu F, Dong P, Chen B and
Zhou MT: MicroRNA-30a suppresses the activation of hepatic stellate
cells by inhibiting epithelial-to-mesenchymal transition. Cell
Physiol Biochem. 46:82–92. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu J, Zhang Z, Zhang Y, Li W, Zheng W, Yu
J, Wang B, Chen L, Zhuo Q, Chen L, et al: MicroRNA-212 activates
hepatic stellate cells and promotes liver fibrosis via targeting
SMAD7. Biochem Biophys Res Commun. 496:176–183. 2018. View Article : Google Scholar : PubMed/NCBI
|
